title: Recombinant alpha-interferon plus vinblastine in metastatic renal-cell cancer: analysis of response and survival in 58 evaluable patients.
authors.affiliation: Service d'Onco-Hématologie, CHU de Strasbourg, France.
authors.forename: J P
authors.initials: JP
authors.lastname: Bergerat
authors.forename: J
authors.initials: J
authors.lastname: Ford
authors.forename: R
authors.initials: R
authors.lastname: Herbrecht
authors.forename: P
authors.initials: P
authors.lastname: Dufour
authors.forename: F
authors.initials: F
authors.lastname: Oberling
authors.forename: D
authors.initials: D
authors.lastname: Jacqmin
authors.forename: C
authors.initials: C
authors.lastname: Bollack
authors.forename: G
authors.initials: G
authors.lastname: Prevot
authors.forename: P
authors.initials: P
authors.lastname: Salze
authors.forename: F
authors.initials: F
authors.lastname: Jurascheck
mesh_terms: D000328:Adult; D000368:Aged; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007370:Interferon Type I / Q000008:administration & dosage / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy; D011994:Recombinant Proteins; D012074:Remission Induction; D015996:Survival Rate; D014747:Vinblastine / Q000627:therapeutic use*
chemical_list: D007155:Immunologic Factors; D007370:Interferon Type I; D011994:Recombinant Proteins; D014747:Vinblastine